In vitro examination of the effect of Orlistat on the ability of the faecal microbiota to utilize dietary lipids
Orlistat is an anti-obesity treatment with which several gastrointestinal (GI) side-effects are commonly associated in the initial stages of therapy. There is no physiological explanation as to why two-thirds of those who take the drug experience one or more side-effects. It has been hypothesized th...
| Main Author: | |
|---|---|
| Published: |
University of Reading
2009
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.515714 |